rs61737003
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_002168.4(IDH2):c.996C>T(p.Ser332=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0252 in 1,557,252 control chromosomes in the GnomAD database, including 1,945 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.072 ( 915 hom., cov: 32)
Exomes 𝑓: 0.020 ( 1030 hom. )
Consequence
IDH2
NM_002168.4 synonymous
NM_002168.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -5.13
Genes affected
IDH2 (HGNC:5383): (isocitrate dehydrogenase (NADP(+)) 2) Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. Each NADP(+)-dependent isozyme is a homodimer. The protein encoded by this gene is the NADP(+)-dependent isocitrate dehydrogenase found in the mitochondria. It plays a role in intermediary metabolism and energy production. This protein may tightly associate or interact with the pyruvate dehydrogenase complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 15-90085359-G-A is Benign according to our data. Variant chr15-90085359-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 158669.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-90085359-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-5.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.203 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IDH2 | NM_002168.4 | c.996C>T | p.Ser332= | synonymous_variant | 8/11 | ENST00000330062.8 | NP_002159.2 | |
IDH2 | NM_001289910.1 | c.840C>T | p.Ser280= | synonymous_variant | 8/11 | NP_001276839.1 | ||
IDH2 | NM_001290114.2 | c.606C>T | p.Ser202= | synonymous_variant | 6/9 | NP_001277043.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IDH2 | ENST00000330062.8 | c.996C>T | p.Ser332= | synonymous_variant | 8/11 | 1 | NM_002168.4 | ENSP00000331897 | P1 | |
IDH2 | ENST00000540499.2 | c.840C>T | p.Ser280= | synonymous_variant | 8/11 | 2 | ENSP00000446147 | |||
IDH2 | ENST00000559482.5 | c.669C>T | p.Ser223= | synonymous_variant | 6/8 | 5 | ENSP00000453016 | |||
IDH2 | ENST00000560061.1 | c.*621C>T | 3_prime_UTR_variant, NMD_transcript_variant | 6/9 | 2 | ENSP00000453254 |
Frequencies
GnomAD3 genomes AF: 0.0718 AC: 10918AN: 152066Hom.: 906 Cov.: 32
GnomAD3 genomes
AF:
AC:
10918
AN:
152066
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0282 AC: 4639AN: 164566Hom.: 266 AF XY: 0.0242 AC XY: 2102AN XY: 86964
GnomAD3 exomes
AF:
AC:
4639
AN:
164566
Hom.:
AF XY:
AC XY:
2102
AN XY:
86964
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0201 AC: 28254AN: 1405068Hom.: 1030 Cov.: 32 AF XY: 0.0194 AC XY: 13434AN XY: 693674
GnomAD4 exome
AF:
AC:
28254
AN:
1405068
Hom.:
Cov.:
32
AF XY:
AC XY:
13434
AN XY:
693674
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0720 AC: 10951AN: 152184Hom.: 915 Cov.: 32 AF XY: 0.0701 AC XY: 5217AN XY: 74394
GnomAD4 genome
AF:
AC:
10951
AN:
152184
Hom.:
Cov.:
32
AF XY:
AC XY:
5217
AN XY:
74394
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
84
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 01, 2021 | - - |
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 29, 2016 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 31, 2013 | - - |
D-2-hydroxyglutaric aciduria 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at